REC630-Therapeutic Recombinant HBV Vaccine

We plan to develop a therapeutic recombinant HBV vaccine (i.e., REC630) based on the same yeast expression system as the HPV vaccine, combined with the enhanced immune effects of the novel adjuvant,The project is currently in the preclinical research stage.